NeuroDerm (NDRM) Misses Q2 EPS by 12c

August 25, 2016 7:27 AM EDT
Get Alerts NDRM Hot Sheet
Trade NDRM Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NeuroDerm (NASDAQ: NDRM) reported Q2 EPS of ($0.44), $0.12 worse than the analyst estimate of ($0.32).

As of June 30, 2016, the Company had cash and cash equivalents and short-term bank deposits totaling $89.8 million.

For earnings history and earnings-related data on NeuroDerm (NDRM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment